Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Worldwide adult obesity has more than doubled since 1990, and, even more shockingly, adolescent obesity has quadrupled, becoming an ever-growing health threat. The latest figures from the World Health ...

Gene therapy represents a transformative approach in modern medicine, with the potential to address and cure a wide array of genetic disorders. By introducing, modifying, or repairing genetic material ...

Aplagon is developing novel treatments for thromboinflammatory diseases. Its lead candidate, APAC, is a first-in-class therapeutic designed to act locally at sites of vascular injury by combining ...